Vision Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Vision Capital Management's IBB Position: Q1 2026 in Review
Vision Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,500 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #131.
Vision Capital Management first reported a position in IBB in Q3 2025 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Vision Capital Management held 1,500 shares of iShares Biotechnology ETF worth $253K as of Q1 2026.
- Vision Capital Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.03% of Vision Capital Management's portfolio in Q1 2026, its #131 holding.
- Vision Capital Management first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Vision Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.